JAKARTA, KOMPAS.com – Indonesia’s state-owned pharmaceutical company Bio Farma will produce more Covid-19 vaccine after receiving the bulk vaccine from China’s Sinovac shortly.
“We have made an agreement with Sinovac who will send 140 million doses of Covid-19 bulk vaccine based on the agreed timeline,” said Bio Farma president director Honesti Basyir in a press conference on Tuesday, February 16.
Also read: BPOM Greenlights Sinovac Covid-19 Vaccine Manufactured by Bio Farma
This announcement was made following the production of 13 million doses of ready-to-use vaccine by Bio Farma. Previously, the company received 15 million doses of bulk vaccine from Sinovac on January 12.
"This achievement will certainly be an encouragement for us to maintain the stability of the supply of the covid-19 vaccine," said Honesti.
Also read: Indonesian Traditional Market Traders to Get Covid-19 Vaccine in Stages
He further added with the issuance of the Emergency Use Authorization (EUA) for the Covid-19 vaccine, Bio Farma would distribute 7.5 million doses of ready-to-use vaccine for the second phase of the mass vaccination program.
“The 7.5 million doses will be provided for non-healthcare workers,” he said.
(Writer: Haryanti Puspa Sari | Editor: Diamanty Meiliana)
Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.